133 related articles for article (PubMed ID: 38286872)
1. Serum level of YWHAG as a diagnostic marker of cognitive impairment in Parkinson's disease patients.
Peng Y; Zhu L; Bai Q; Wang L; Li Q
Acta Neurol Belg; 2024 Jun; 124(3):879-885. PubMed ID: 38286872
[TBL] [Abstract][Full Text] [Related]
2. Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease.
Zhu Y; Yang B; Wang F; Liu B; Li K; Yin K; Yin WF; Zhou C; Tian S; Ren H; Pang A; Yang X
J Neuroimmunol; 2021 Sep; 358():577662. PubMed ID: 34311152
[TBL] [Abstract][Full Text] [Related]
3. Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease.
Pagonabarraga J; Pérez-González R; Bejr-Kasem H; Marín-Lahoz J; Horta-Barba A; Martinez-Horta S; Aracil-Bolaños I; Sampedro F; Campolongo A; Rivas E; Puig-Davi A; Ruiz-Barrios I; Pérez-Pérez J; Pascual-Sedano B; Kulisevsky J
Parkinsonism Relat Disord; 2022 Dec; 105():132-138. PubMed ID: 35752549
[TBL] [Abstract][Full Text] [Related]
4. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.
Chen CH; Lee BC; Lin CH
J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681
[TBL] [Abstract][Full Text] [Related]
5. Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease.
Sampedro F; Pérez-González R; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
Parkinsonism Relat Disord; 2020 May; 74():43-49. PubMed ID: 32334380
[TBL] [Abstract][Full Text] [Related]
6. Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
Dong L; Chang Q; Ma J; Liu C; Guo D; Li X; Yang D; Fan Y; Liang K; Li D; Gu Q
Neurosci Lett; 2023 May; 804():137219. PubMed ID: 37023526
[TBL] [Abstract][Full Text] [Related]
7. Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD).
Niemann L; Lezius S; Maceski A; Leppert D; Englisch C; Schwedhelm E; Zeller T; Gerloff C; Kuhle J; Choe CU
Parkinsonism Relat Disord; 2021 Sep; 90():44-48. PubMed ID: 34352610
[TBL] [Abstract][Full Text] [Related]
8. Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.
Fengler S; Kessler J; Timmermann L; Zapf A; Elben S; Wojtecki L; Tucha O; Kalbe E
PLoS One; 2016; 11(7):e0159318. PubMed ID: 27437705
[TBL] [Abstract][Full Text] [Related]
9. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
[TBL] [Abstract][Full Text] [Related]
11. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
[TBL] [Abstract][Full Text] [Related]
12. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
[TBL] [Abstract][Full Text] [Related]
13. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
[TBL] [Abstract][Full Text] [Related]
14. Correlation between serum 25(OH)D and cognitive impairment in Parkinson's disease.
Wu H; Khuram Raza H; Li Z; Li Z; Zu J; Xu C; Yang D; Cui G
J Clin Neurosci; 2022 Jun; 100():192-195. PubMed ID: 35489254
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale.
Garon M; Weis L; Siquier A; Fiorenzato E; Pistonesi F; Cianci V; Canesi M; Pesce F; Reali E; Pozzi B; Isaias IU; Siri C; Santangelo G; Cuoco S; Barone P; Kulisevsky J; Antonini A; Biundo R
J Neural Transm (Vienna); 2024 Apr; 131(4):305-314. PubMed ID: 38280057
[TBL] [Abstract][Full Text] [Related]
16. Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology.
Liu HC; Lin WC; Chiu MJ; Lu CH; Lin CY; Yang SY
PLoS One; 2020; 15(6):e0234519. PubMed ID: 32530970
[TBL] [Abstract][Full Text] [Related]
17. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease.
Lin YS; Lee WJ; Wang SJ; Fuh JL
Sci Rep; 2018 Nov; 8(1):17368. PubMed ID: 30478269
[TBL] [Abstract][Full Text] [Related]
18. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
[TBL] [Abstract][Full Text] [Related]
19. The MemTrax memory test for detecting and assessing cognitive impairment in Parkinson's disease.
Liu Y; Wu L; Chen W; Su F; Liu G; Zhou X; Ashford CB; Li F; Ashford JW; Pei Z; Xian W
Parkinsonism Relat Disord; 2024 Mar; 120():106016. PubMed ID: 38325255
[TBL] [Abstract][Full Text] [Related]
20. Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease.
Ma LZ; Zhang C; Wang H; Ma YH; Shen XN; Wang J; Tan L; Dong Q; Yu JT
J Parkinsons Dis; 2021; 11(3):1117-1127. PubMed ID: 33935105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
